MALAT1 and pulmonary fibrosis: Knocking out MALAT1 reduced LPS-induced systemic and pulmonary inflammation and injury, but more severe bleomycin-induced pulmonary fibrosis and M2 alveolar macrophage augmentation were observed in mice (30).